Sign in Register Account
Point-of-care testing (POCT), or bedside testing is defined as medical diagnostic testing at or near the point of care—that is, at the time and place of patient care.[1] This contrasts with the historical pattern in which testing was wholly or mostly confined to the medical laboratory, which entailed sending off specimens away from the point of care and then waiting hours or days to learn the results, during which time care must continue without the desired information.
 
Point-of-care tests are simple medical tests that can be performed at the bedside. In many cases the simplicity was not achievable until technology developed not only to make a test possible at all but then also to mask its complexity. For example, various kinds of urine test strips have been available for decades, but portable ultrasonography did not reach the stage of being advanced, affordable, and widespread until the 2000s and 2010s. Today portable US is often viewed as a "simple" test, but there was nothing simple about it until the more complex technology was available. Similarly, pulse oximetry can test arterial oxygen saturation in a quick, simple, noninvasive, affordable way today, but in earlier eras this required an intraarterial needle puncture and a laboratory test; and rapid diagnostic tests such as malaria antigen detection tests rely on a state of the art in immunology that did not exist until recent decades. Thus, over decades, testing continues to move toward the point of care more than it formerly had been. A recent survey in five countries (Australia, Belgium, the Netherlands, the UK and the US) indicates that general practitioners / family doctors would like to use more POCTs.
 
The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for better immediate clinical management decisions to be made. POCT includes: blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing (PT/INR, Alere, Microvisk Ltd), rapid cardiac markers diagnostics (TRIAGE, Alere), drugs of abuse screening, urine strips testing, pregnancy testing, fecal occult blood analysis, food pathogens screening, hemoglobin diagnostics (HemoCue), infectious disease testing and cholesterol screening.
 
POCT is often accomplished through the use of transportable, portable, and handheld instruments (e.g., blood glucose meter, nerve conduction study device) and test kits (e.g., CRP, HBA1C, Homocystein, HIV salivary assay, etc.). Small bench analyzers or fixed equipment can also be used when a handheld device is not available—the goal is to collect the specimen and obtain the results in a very short period of time at or near the location of the patient so that the treatment plan can be adjusted as necessary before the patient leaves. Cheaper, faster, and smarter POCT devices have increased the use of POCT approaches by making it cost-effective for many diseases, such as diabetes, carpal tunnel syndrome (CTS) and acute coronary syndrome. Additionally, it is very desirable to measure various analytes simultaneously in the same specimen, allowing a rapid, low-cost, and reliable quantification. Therefore, multiplexed point-of-care testing (xPOCT) has become more important for medical diagnostics in the last decade.
MSLRDT013 Tuberculosis Rapid Test Dipstick | Rapid Test
Product Name:  MSLRDT013 Tuberculosis Rapid Test Dipstick | Rapid Test
Latest Price:
Model No.:  MSLRDT013
Weight:  Net weight: Kg
Minimum Order Quantity:  1 Set Set/Sets
Supply Ability:  300 Sets per Year
Payment Terms:  T/T,L/C,D/A,D/P,Western Union,MoneyGram,PayPal
Size:  
Color:  
QTY:  

Quick Details

1. Fast.

2. High sensitivity and specificity.

3. Simple to use.

4. Accurate and reliable.

5. Ambient storage.

6. IgG, IgM and IgA can be detected.

Packaging & Delivery

Packaging detail:Standard export package
Delivery detail:within 7-10 workdays after receipt of payment

Specifications

MSLRDT013 Tuberculosis Rapid Test Dipstick | Rapid Test

A rapid  test for the qualitative  detection of anti-TB  antibodies (Isotypes IgG,  IgM and IgA)  in whole

blood, serum or plasma specimens.

INTENDED USE

A procedural control  is included in the  test. A colored line  appearing in the  control region (C) is the

internal procedural control. It confirms sufficient  specimen volume and correct procedural technique.

Control  standards  are  not  supplied  with this  kit;  however,  it  is  recommended  that  positive  and

negative controls be tested  as a good laboratory practice to  confirm the test procedure and to verify

proper test  performance. Some preservatives  may interfere  with the operation  of the  test. External

controls should be validated before use to ensure valid results.

point of care testing

LIMITATIONS

1.  The Tuberculosis Rapid Test  Dipstick (Whole Blood/Serum/Plasma)  is for in vitro  diagnostic use

only.

The  Tuberculosis  Rapid  Test  Dipstick  (Whole Blood/Serum/Plasma)  is  a  rapid  chromatographic

immunoassay for the qualitative detection of anti-TB  antibodies (Isotypes IgG, IgM and IgA) in whole

blood, serum or plasma specimens.

MSLRDT013 Tuberculosis Rapid Test Dipstick | Rapid Test

1. Fast.

2. High sensitivity and specificity.

3. Simple to use.

4. Accurate and reliable.

5. Ambient storage.

6. IgG, IgM and IgA can be detected.

Catalog No.

MSLRDT013

Product name

Tuberculosis Rapid Test Dipstick (Whole Blood/Serum/Plasma)

Analyte

Isotypes IgG, IgM and IgA

Test method

Colloidal Gold

Sample type

WB/Serum/Plasma

Sample volume

3 drops

Reading time

10 mins

Sensitivity

86.40%

Specificity

99.0%

Storage

2~30℃

Shelf life

24 months

Qualification

CE

Format

Strip

Package

50T/kit

MSLRDT013 Tuberculosis Rapid Test Dipstick | Rapid Test

【PRINCIPLE】
The  Tuberculosis Rapid  Test  Dipstick (Whole  Blood/Serum/Plasma)  is a  qualitative,  solid phase, two-site  sandwich immunoassay  for the  detection of  anti-TB  antibodies in  whole  blood, serum  or plasma specimens. The membrane is pre-coated with TB recombinant antigen on the test line region of the  Dipstick. During  testing, the  anti-TB antibodies,  if present  in whole  blood, serum  or plasma specimen react with the particles coated  with TB recombinant antigen. The mixture migrates upward on the membrane chromatographically by capillary action to react with TB recombinant antigen on the membrane and generate a colored line. The presence of this colored line in the test region indicates a positive result,  while  its absence  indicates a  negative result.  To  serve as  a procedural  control, a
colored line  will always appear  in the control  line region indicating that  proper volume of  specimen has been added and membrane wicking has occurred.
【REAGENTS】
The  test Dipstick  contains  TB recombinant  antigen  coated particles  and TB  recombinant  antigen coated on the membrane.

MSL TEAM picture 

MSL TEAM

MSL customer group photo

 

MSL Certificate

MSL certificate photo

MSL Medical cooperate with DHL,FEDEX,UPS,EMS,TNT,etc.International shipping company,make your goods​ arrive destination safely and quickly.

MSL International shipping
 

Welcome to medicalequipment-msl.com,If you have any demand in ultrasound machine.

Please feel free to contact cindy@medicalequipment-msl.com.

MSL coupon

 

Product Inquire

Full name:*
Subject:*
Email:*
City:*
Tel:
Phone:
State:*
Message:*
  

Related Products

Connect Alwaysx

Connect us in Whatsapp or Facebook Messenger

Messenger

whatsapp